GSK 650394 is a glucocorticoid- and serum-regulated kinase 1 (SGK1) inhibitor which displays antiproliferative properties against the LNCaP prostate carcinoma cell line.
More Information Supplier PageGSK 650394 is a glucocorticoid- and serum-regulated kinase 1 (SGK1) inhibitor which displays antiproliferative properties against the LNCaP prostate carcinoma cell line.
More Information Supplier PageGSK 650394 is a glucocorticoid- and serum-regulated kinase 1 (SGK1) inhibitor which displays antiproliferative properties against the LNCaP prostate carcinoma cell line.
More Information Supplier PageGSK 650394 is a glucocorticoid- and serum-regulated kinase 1 (SGK1) inhibitor which displays antiproliferative properties against the LNCaP prostate carcinoma cell line.
More Information Supplier PagePalosuran is a new potent and specific antagonist of the human UT receptor with an IC50 of 3.6??0.2 nM.
More Information Supplier PagePalosuran is a new potent and specific antagonist of the human UT receptor with an IC50 of 3.6??0.2 nM.
More Information Supplier PagePalosuran is a new potent and specific antagonist of the human UT receptor with an IC50 of 3.6??0.2 nM.
More Information Supplier Page
